Page last updated: 2024-08-24

tenofovir and Genital Tract Infections

tenofovir has been researched along with Genital Tract Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cottrell, M; Dellon, ES; Gonzalez, D; Kashuba, ADM; Madanick, RD; Maffuid, K; Nelson, JAE; Prince, HA; Shaheen, NJ; Srinivas, N; Sykes, C; White, N1
Frieboes, HB; Halwes, ME; Steinbach-Rankins, JM; Tyo, KM1
Blake, KH; Chen, J; Cohen, MS; Dumond, JB; Gay, CL; Greene, SA; Kashuba, ADM; Maas, BM; Nelson, JAE; Prince, HMA; Schauer, AP; Sykes, C1
Agrahari, V; Christenson, LK; Dim, DC; Ezoulin, MJ; Hung, WT; Meng, J; Molteni, A; Youan, BC; Youm, I1

Other Studies

4 other study(ies) available for tenofovir and Genital Tract Infections

ArticleYear
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.
    Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cohort Studies; Computer Simulation; Demography; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Maraviroc; Pre-Exposure Prophylaxis; Reproductive Tract Infections; Tenofovir; Treatment Outcome

2020
Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.
    Molecular pharmaceutics, 2018, 04-02, Volume: 15, Issue:4

    Topics: Anti-HIV Agents; Computer Simulation; Diffusion; Epithelium; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Polyesters; Reproductive Tract Infections; Reverse Transcriptase Inhibitors; Tenofovir

2018
Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tract.
    Antiviral therapy, 2019, Volume: 24, Issue:1

    Topics: Adenine; Anti-Retroviral Agents; Blood Cells; Emtricitabine; Genitalia, Male; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Reproductive Tract Infections; Semen; Tenofovir

2019
Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity.
    Nanomedicine (London, England), 2016, Volume: 11, Issue:22

    Topics: Animals; Anti-HIV Agents; Drug Liberation; Female; HIV Infections; Humans; Hyaluronic Acid; Mice; Nanofibers; Reproductive Tract Infections; Sulfhydryl Compounds; Tenofovir; Vagina

2016